Genome-wide identification of cancer-specific alternative splicing in circRNA

• Published in: Molecular cancer Vol. 18; no. 1; pp. 35 - 5
• Main Authors: Feng, Jing, Chen, Ke, Dong, Xin, Xu, Xiaolong, Jin, Yuxuan, Zhang, Xinyang, Chen, Wenbo, Han, Yujing, Shao, Lin, Gao, Yang, He, Chunjiang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.03.2019; BioMed Central; BMC
• Subjects: Algorithms; Alternative Splicing; Analysis; Bladder cancer; Cancer; Cancer diagnosis; Cancer genetics; Cancer research; Cancer-specific; Carcinoma; Carcinoma, Renal Cell - genetics; ccRCC; circRNAs; Circular RNA; Circular RNAs; Clear cell-type renal cell carcinoma; Databases, Factual; Exons; Genome, Human; Genomes; Genomics; Humans; Identification; Introns; Kidney cancer; Kidney Neoplasms - genetics; Laboratories; Letter to Editor; Polymerase chain reaction; Renal cell carcinoma; Ribonucleic acid; RNA; RNA - genetics; RNA, Neoplasm - genetics; Senescence; Tumors; Urinary Bladder Neoplasms - genetics; China; Alternative splicing; circRNAs; ccRCC; Cancer-specific; Circular RNAs
• ISSN: 1476-4598; 1476-4598
• DOI: 10.1186/s12943-019-0996-0

Circular RNA (circRNA) is a group of RNA families generated by RNA circularization, which was discovered ubiquitously across different cancers. However, the internal structure of circRNA is difficult to determine due to alternative splicing that occurs in its exons and introns. Furthermore, cancer-specific alternative splicing of circRNA is less likely to be identified. Here, we proposed a de novo algorithm, CircSplice, that could identify internal alternative splicing in circRNA and compare differential circRNA splicing events between different conditions ( http://gb.whu.edu.cn/CircSplice or https://github.com/GeneFeng/CircSplice ). By applying CircSplice in clear cell renal cell carcinoma and bladder cancer, we detected 4498 and 2977 circRNA alternative splicing (circ-AS) events in the two datasets respectively and confirmed the expression of circ-AS events by RT-PCR. We further inspected the distributions and patterns of circ-AS in cancer and adjacent normal tissues. To further understand the potential functions of cancer-specific circ-AS, we classified those events into tumor suppressors and oncogenes and performed pathway enrichment analysis. This study is the first comprehensive view of cancer-specific circRNA alternative splicing, which could contribute significantly to regulation and functional research of circRNAs in cancers.